bisbenzimidazole and gw-5074

bisbenzimidazole has been researched along with gw-5074 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cui, C; Ding, HF; Fan, Y; Fu, SB; Jiang, LH; Li, J; Ma, L; Sun, DJ; Yang, J; Zhang, YN	1

Other Studies

1 other study(ies) available for bisbenzimidazole and gw-5074

Article	Year
The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine. Die Pharmazie, 2012, Volume: 67, Issue:8 Topics: Apoptosis; Bisbenzimidazole; Blotting, Western; Butadienes; Cell Survival; Enzyme Inhibitors; Flow Cytometry; Humans; Indicators and Reagents; Indoles; MAP Kinase Signaling System; Nitriles; Oxidopamine; Parkinson Disease; PC12 Cells; Phenols; Phosphorylation; Proto-Oncogene Proteins c-raf	2012

Article

Year

The Raf-1 inhibitor GW5074 and the ERK1/2 pathway inhibitor U0126 ameliorate PC12 cells apoptosis induced by 6-hydroxydopamine.

Die Pharmazie, 2012, Volume: 67, Issue:8

Topics: Apoptosis; Bisbenzimidazole; Blotting, Western; Butadienes; Cell Survival; Enzyme Inhibitors; Flow Cytometry; Humans; Indicators and Reagents; Indoles; MAP Kinase Signaling System; Nitriles; Oxidopamine; Parkinson Disease; PC12 Cells; Phenols; Phosphorylation; Proto-Oncogene Proteins c-raf

2012